Updates on the Treatment and Management of Large Vessel Vasculitis
Canadian Rheumatology Today · 10.07.2026 · 27-34
DOI: 10.58931/crt.2026.3172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Rheumatology Today, online erschienen am 10.07.2026. Verfasst von Stephanie Garner,. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Large vessel vasculitis (LVV), encompassing giant cell arteritis (GCA) and Takayasu arteritis (TAK), causes granulomatous inflammation of large- and medium-sized arteries with potentially devastating ischemic complications. Glucocorticoids remain first-line therapy but carry significant long‑term morbidity.
Methods
This narrative review synthesizes current evidence on the classification, diagnosis, monitoring, and management of LVV, incorporating data from randomized controlled trials, meta‑analyses, and international guidelines.
Results
Advances in vascular imaging have improved diagnostic accuracy and increasingly supplement or replace temporal artery biopsy. In GCA, phase 3 trials have demonstrated that tocilizumab and upadacitinib have superior remission rates and glucocorticoid-sparing effects. In TAK, tumour necrosis factor inhibitors remain the preferred biologic for refractory disease, with emerging evidence supporting Janus kinase (JAK) inhibition and novel disease-modifying anti-rheumatic drug combinations.
Conclusion
Targeted therapies have transformed LVV management, though reliable biomarkers for disease activity and consensus on optimal treatment duration remain unmet needs. Keywords: large vessel vasculitis, giant cell arteritis, Takayasu arteritis, tocilizumab, upadacitinib, glucocorticoid-sparing, JAK inhibitors
Zitieren
APA
Garner,, S. (2026). Updates on the Treatment and Management of Large Vessel Vasculitis. Canadian Rheumatology Today, 27-34. https://doi.org/10.58931/crt.2026.3172
Vancouver
Garner, S. Updates on the Treatment and Management of Large Vessel Vasculitis. Canadian Rheumatology Today. 2026:27-34. doi:10.58931/crt.2026.3172
BibTeX
@article{Garner2026,
author = {Garner,, Stephanie},
title = {Updates on the Treatment and Management of Large Vessel Vasculitis},
journal = {Canadian Rheumatology Today},
year = {2026},
pages = {27--34},
doi = {10.58931/crt.2026.3172}
}
EUVIMED